Clinical Trial Update: Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial comparing brivanib with best supportive care to placebo in liver cancer patients after sorafenib failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Brivanib (brivanib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Liver Cancer | Phase 3 | Status: COMPLETED